The evolution of diabetic retinopathy screening
Eye · 2025-04 · 39 (6) · 1040-1046
DOI: 10.1038/s41433-025-03633-4 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Eye, online erschienen am 05.02.2025. Verfasst von Anushka Irodi und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Clinical Medicine, University of Cambridge, Cambridge, United Kingdom. Hauptthemen laut MEDLINE: Diabetic Retinopathy, Mass Screening. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 100 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Diabetic retinopathy (DR) is a leading cause of preventable blindness and has emerged as a global health challenge, necessitating the development of robust management strategies. As DR prevalence continues to rise, advancements in screening methods have become increasingly critical for timely detection and intervention. This review examines three key advancements in DR screening: a shift from specialist to generalist approach, the adoption of telemedicine strategies for expanded access and enhanced efficiency, and the integration of artificial intelligence (AI). In particular, AI offers unprecedented benefits in the form of sustainability and scalability for not only DR screening but other aspects of eye health and the medical field as a whole. Though there remain barriers to address, AI holds vast potential for reshaping DR screening and significantly improving patient outcomes globally.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- School of Clinical Medicine, University of Cambridge, Cambridge, United Kingdom.
- Centre for Eye Research Australia, Ophthalmology, University of Melbourne, Melbourne, Australia.
- Department of Surgery (Ophthalmology), The University of Melbourne, Melbourne, Australia.
- Department of Ophthalmology, University of Warmia and Mazury, Olsztyn, Poland.
- Institute for Research in Ophthalmology, Foundation for Ophthalmology Development, Poznan, Poland.
- Tsinghua Medicine, Tsinghua University, Beijing, China.
Zitieren
APA
Irodi, A., Zhu, Z., Grzybowski, A., Wu, Y., Cheung, C. Y., Li, H., Tan, G., & Wong, T. Y. (2025). The evolution of diabetic retinopathy screening. Eye, 39(6), 1040-1046. https://doi.org/10.1038/s41433-025-03633-4
Vancouver
Irodi A, Zhu Z, Grzybowski A, Wu Y, Cheung CY, Li H, et al. The evolution of diabetic retinopathy screening. Eye. 2025;39(6):1040-1046. doi:10.1038/s41433-025-03633-4
BibTeX
@article{Irodi2025,
author = {Irodi, Anushka and Zhu, Zhuoting and Grzybowski, Andrzej and Wu, Yilan and Cheung, Carol Y and Li, Huating and Tan, Gavin and Wong, Tien Yin},
title = {The evolution of diabetic retinopathy screening},
journal = {Eye},
year = {2025},
volume = {39},
number = {6},
pages = {1040--1046},
doi = {10.1038/s41433-025-03633-4}
}
EUVIMED